New dosing for Viracept
This article was originally published in Pharmaceutical Approvals Monthly
Executive SummaryNew dosage strength of Pfizer's Viracept, approved April 30, reduces pill burden from five 250 mg tablets to two 625 mg tablets twice daily. Nelfinavir is indicated for the treatment of HIV-1 as part of a combination regime
You may also be interested in...
Drug companies in the EU explain how a new pilot scheme on national-level scientific advice service can benefit drug developers.
India’s Indoco Remedies is looking for healthy revenue growth in the coming fiscal year after beating market estimates with a 70.4% year-on-year jump in after-tax profit in its financial third quarter, propelled by strong revenues from domestic and international markets.
The Committee on Energy and Commerce of the US House of Representatives has requested a set of documents from the FDA in order to assess whether the agency is doing enough to address the challenge of approving complex generics within its existing authorities, or whether additional authority is needed.